Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE:524494

₹1175.75 22.30 (1.93%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1149.00

Today’s High

1181.20

52W low

743.00

52W High

1374.60

Open Price

1162.00

Prev. Close

1161.7500

Volume

660697.00

Value

776814497.75

Fundamentals

Market Cap Cr

29829.30

Price to Earnings

54.50

Price to Book Value

3.90

Dividend Yield

0.20

PE to Growth

3.40

Op Revenue TTM Cr

7707.41

Net Profit TTM Cr

547.35

Cash From Operating Activity Cr

944.65

Return on Equity %

8.64

EMA & SMA

Bullish Moving Averages

10

Bearish Moving Averages

6

5Day EMA

1134.8

10Day EMA

1134.6

12Day EMA

1137.4

20Day EMA

1153.8

26Day EMA

1166.5

50Day EMA

1197.4

100Day EMA

1195.6

200Day EMA

1134.4

5Day SMA

1127.6

10Day SMA

1123.4

20Day SMA

1147.5

30Day SMA

1181.8

50Day SMA

1235.4

100Day SMA

1229.8

150Day SMA

1190.2

200Day SMA

1135.8

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

37.1

Week

50.5

Month

53.7

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1151.42

PIVOT

First Resistance

1174.83

Second Resistance

1196.22

Third Resistance

1219.63

First Support

1130.03

Second Support

1106.62

Third Support

1085.23

Relative Strength Index

46.65

Money Flow Index

42.2

MACD

-29.07

MACD Signal

-34.52

Average True Range

36.56

Average Directional Index

33.83

Rate of Change (21)

2.32

Rate of Change (125)

3.05

Commodity Channel Index

8

Williams %R

-37.3

BETA

1 Month

-0.08

3 Month

0.04

1 Year

0.4

3 Year

0.03

PRICE CHANGE ANALYSIS

↑ 6.18%

1 Week

Low

High

1052

1181.15

↑ 4.3%

1 Month

Low

High

1052

1213.7

↓ -3.97%

3 Months

Low

High

1052

1374.6

↑ 5.9%

6 Months

Low

High

1052

1374.6

↑ 57.46%

1 Year

Low

High

743.05

1374.6

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 1525.72 1523.72 1698.81 1531.87 1435.10 1458.09 1521.47 1488.09 1182.66 1341.71 1438.91
Operating Expenses Qtr 1218.28 1233.34 1353.69 1191.18 1225.99 1218.80 1212.94 1211.83 989.43 1016.95 1064.82
Operating Profit Qtr 292.34 273.49 308.98 297.53 175.64 213.99 271.94 257.45 179.02 311.52 359.02
EBIDT Qtr Cr 213.12 290.38 345.12 340.69 209.11 239.29 308.53 276.26 193.23 324.76 374.09
Depreciation Qtr 61.76 63.02 61.35 60.35 59.21 57.03 54.92 53.41 52.39 51.25 50.50
Net Profit Qtr 64.76 136.94 162.13 166.58 84.82 120.27 167.78 143.82 110.41 218.17 257.64
Basic EPS Qtr 2.55 5.40 6.39 6.57 3.34 4.74 6.61 5.67 4.35 8.60 20.31
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 6277.75 5925.81 5455.49 5201.40 4432.12
Operating Expenses Annual Cr 4955.08 4902.77 4155.82 3625.58 3452.67
Operating Profit Annual 1211.38 911.85 1243.54 1513.58 914.76
Operating Profit Margin Annual % 19.30 15.39 22.79 29.10 20.64
Total Expenses Annual Cr 5322.23 5175.32 4367.13 3821.44 3647.15
EBIDT Annual Cr 1322.67 1023.04 1299.67 1575.82 979.45
EBIDT Annual margin % 21.07 17.26 23.82 30.30 22.10
Depreciation 246.48 228.63 204.10 187.72 178.69
PAT Before ExtraOrdinary Items Annual Cr 530.41 505.70 870.94 1140.77 652.46
Net Profit Annual 530.41 505.70 870.94 1140.77 652.46
Basic EPS Annual 20.91 19.93 34.33 90.08 51.64
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 6348.71 5877.30 5523.34 4752.72 3677.54
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 790.39 891.89 604.22 191.82 265.43
Total Current Liabilities Annual Cr 1520.17 1677.78 1339.30 1065.59 1241.60
Total Capital Plus Liabilities Annual Cr 8659.27 8446.97 7466.86 6010.13 5184.57
Fixed Assets Annual 2698.90 2601.68 2373.82 2050.60 1925.16
Total Non Current Assets Annual 5149.38 3571.82 3275.94 2732.34 2472.46
Total Current Assets Annual 3509.89 4875.15 4190.92 3277.79 2712.11
Total Assets Annual 8659.27 8446.97 7466.86 6010.13 5184.57
Contingent Liabilities plus Commitments Annual Cr - 2161.85 287.71 382.20 219.49
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 830.51 762.29 840.14 1096.06 554.35
Cash from Investing Activity Annual -1355.18 -709.61 -823.89 -559.56 -498.13
Cash from Financing Annual Activity -464.88 506.38 426.10 -307.38 -132.59
Net Cash Flow Annual - 559.06 442.35 229.12 -76.37
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 250.24 231.66 217.71 374.67 291.06
ROE Annual % 8.35 8.60 15.76 24.00 17.74
ROCE Annual % 15.07 11.73 17.87 28.07 20.30
Total Debt to Total Equity Annual 0.18 0.24 0.14 0.05 0.11
EBDIT Annual Margin % 21.44 17.59 24.07 30.66 22.42
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 2051.93 2075.31 2072.51 1632.43 1548.02 1576.69 1637.18 1607.85 1303.64 1443.40 1562.51
Operating Expenses Qtr 1711.11 1721.53 1712.69 1279.96 1330.59 1329.94 1340.31 1316.51 1069.77 1122.66 1178.85
Operating Profit Qtr 321.90 331.33 321.27 307.62 181.04 216.06 260.64 269.23 219.33 307.81 365.58
EBIDT Qtr Cr 204.10 421.79 359.82 352.47 217.43 246.75 296.87 291.34 233.87 320.74 383.66
Depreciation Qtr 98.13 99.50 90.34 69.27 69.54 66.57 63.74 61.71 60.94 58.65 56.96
Net Profit Qtr 59.59 179.88 145.06 162.82 76.52 107.84 143.90 143.06 130.23 196.96 250.23
Basic EPS Qtr 2.35 7.09 5.72 6.42 3.02 4.25 5.67 5.64 5.13 7.76 19.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 7829.81 6369.94 5896.36 5482.83 4715.71
Operating Expenses Annual Cr 6383.88 5317.55 4520.53 3875.64 3742.01
Operating Profit Annual 1321.16 926.77 1309.26 1544.35 906.70
Operating Profit Margin Annual % 16.87 14.55 22.20 28.17 19.23
Total Expenses Annual Cr 6879.39 5624.65 4760.64 4093.85 3969.01
EBIDT Annual Cr 1445.93 1052.39 1375.83 1607.19 973.70
EBIDT Annual margin % 18.47 16.52 23.33 29.31 20.65
Depreciation 357.24 261.56 232.42 209.17 210.50
PAT Before ExtraOrdinary Items Annual Cr 529.21 491.93 910.95 1148.84 611.37
Net Profit Annual 547.35 471.32 884.08 1140.01 606.32
Basic EPS Annual 21.57 18.58 34.85 45.01 47.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 6332.19 5842.02 5491.97 4701.65 3627.48
Minority Interest Liability Annual Cr 1394.81 73.30 76.92 14.53 13.63
Total Non Current Liabilities Annual Cr 1018.64 905.29 604.09 191.64 292.30
Total Current Liabilities Annual Cr 2355.64 1805.82 1465.88 1160.54 1326.42
Total Capital Plus Liabilities Annual Cr 11101.28 8626.43 7638.86 6068.36 5259.83
Fixed Assets Annual 4805.84 2853.67 2669.79 2260.65 2129.57
Total Non Current Assets Annual 5562.38 3437.16 3181.69 2631.40 2404.12
Total Current Assets Annual 5538.90 5189.27 4457.17 3436.96 2855.71
Total Assets Annual 11101.28 8626.43 7638.86 6068.36 5259.83
Contingent Liabilities plus Commitments Annual Cr - 2125.64 274.03 369.48 198.98
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 944.65 805.81 856.04 1090.13 564.27
Cash from Investing Activity Annual -1291.79 -725.00 -855.05 -520.69 -509.65
Cash from Financing Annual Activity -552.55 507.24 426.81 -305.82 -130.46
Net Cash Flow Annual - 588.05 427.80 263.62 -75.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 304.57 233.16 219.51 371.79 288.18
ROE Annual % 8.64 8.06 16.09 24.24 16.71
ROCE Annual % 12.44 11.59 18.52 28.48 19.40
Total Debt to Total Equity Annual 0.22 0.25 0.14 0.05 0.11
EBDIT Annual Margin % 18.76 16.85 23.59 29.65 20.94
Name Holding Percent Holding Id Pledged % Locked %
Hdfc Mutual Fund - Hdfc Mid-Cap Opportunities Fund 7.03 74552939 - -
Kotak Emerging Equity Scheme 3.7 74552940 - -
Icici Prudential Multi-Asset Fund 2.4 74552941 - -
Hdfc Life Insurance Company Limited 1.95 74552946 - -
Kotak Funds - India Midcap Fund 1.36 74552952 - -
Abu Dhabi Investment Authority - Monsoon 1.12 74552953 - -
Name Holding Percent Holding Id Pledged % Locked %
Usha M Chandurkar 3.27 74552918 0 0
Premchand Godha 2.29 74552919 0 0
Usha Premchand Godha 0.95 74552920 0 0
Sameer M Chandurkar 0.79 74552921 0 0
Pranay Godha 0.67 74552922 0 0
Prashant Godha 0.62 74552923 0 0
Kaygee Investments Private Limited 21.47 74552929 0 0
Kaygee Laboratories Private Limited 6.61 74552930 0 0
Chandurkar Investments Private Limited 5.5 74552931 0 0
Paschim Chemicals Pvt Ltd 4.01 74552932 0 0
Name Holding Percent Holding Id
Dsp Midcap Fund 7.13 74552938
Hdfc Mutual Fund - Hdfc Mid-Cap Opportunities Fund 7.03 74552939
Kotak Emerging Equity Scheme 3.7 74552940
Icici Prudential Multi-Asset Fund 2.4 74552941
Nippon Life India Trustee Ltd-A/C Nippon India Growth Fund 1.7 74552942
Parag Parikh Flexi Cap Fund 1.46 74552943
Uti Flexi Cap Fund 1.04 74552944
Kotak Funds - India Midcap Fund 1.36 74552952
Abu Dhabi Investment Authority - Monsoon 1.12 74552953
Hdfc Life Insurance Company Limited 1.95 74552946
Sbi Life Insurance Co. Ltd 1.83 74552947
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Nov 22, 2023 2 INTERIM Nov 22, 2023 Equity Share
Nov 22, 2022 4 INTERIM Nov 23, 2022 Equity Share
Nov 22, 2021 8 INTERIM Nov 23, 2021 Equity Share
Nov 13, 2020 8 INTERIM Nov 17, 2020 Equity Share
Feb 18, 2020 5 INTERIM Feb 20, 2020 Equity Share
Aug 06, 2019 3 FINAL - Equity Share
Aug 02, 2018 1 FINAL - Equity Share
Jul 27, 2017 1 FINAL - Equity Share
Jul 22, 2015 1 FINAL - Equity Share
Jul 18, 2014 2.5 FINAL - Equity Share
Oct 31, 2013 2.5 INTERIM Nov 01, 2013 Equity Share
Jul 19, 2013 2 FINAL - Equity Share
Nov 01, 2012 2 INTERIM Nov 02, 2012 Equity Share
Jul 20, 2012 1.2 FINAL - Equity Share
Feb 07, 2012 1 INTERIM Feb 08, 2012 Equity Share
Nov 03, 2011 1 INTERIM Nov 07, 2011 Equity Share
Jul 18, 2011 1.2 FINAL - Equity Share
Feb 01, 2011 1 INTERIM Feb 02, 2011 Equity Share
Oct 28, 2010 1 INTERIM Oct 29, 2010 Equity Share
Jul 16, 2010 1 FINAL - Equity Share
Jan 27, 2010 4 INTERIM Jan 28, 2010 Equity Share
Oct 30, 2009 5 INTERIM Nov 03, 2009 Equity Share
Jul 20, 2009 4 FINAL - Equity Share
Jan 27, 2009 3 INTERIM Jan 28, 2009 Equity Share
Nov 07, 2008 4 INTERIM Nov 10, 2008 Equity Share
Jul 14, 2008 4.5 FINAL - Equity Share
Nov 06, 2007 3.5 INTERIM Nov 07, 2007 Equity Share
Jul 10, 2007 4 FINAL - Equity Share
Nov 02, 2006 3.5 INTERIM Nov 03, 2006 Equity Share
Jul 18, 2006 3 FINAL - Equity Share
Nov 09, 2005 2.5 INTERIM Nov 10, 2005 Equity Share
Sep 13, 2005 3 FINAL - Equity Share
Nov 04, 2004 5 INTERIM Nov 05, 2004 Equity Share
Jul 02, 2004 6 INTERIM Jul 05, 2004 Equity Share
Nov 07, 2003 5 INTERIM Nov 10, 2003 Equity Share
Jul 24, 2003 9 FINAL - Equity Share
Aug 21, 2002 - FINAL - Equity Share
Jul 10, 2001 - FINAL - Equity Share
Nov 15, 2000 - INTERIM Nov 30, 2000 Equity Share
Ex-Date Split Ratio Record Date
Jan 10, 2022 2:1 2022-01-11
Mar 22, 2010 10:2 2010-03-23
Ex-Date Purpose Notes
May 29, 2024 Audited Results & Final Dividend -
Feb 14, 2024 Quarterly Results -
Nov 10, 2023 Quarterly Results & Interim Dividend -
Aug 10, 2023 Quarterly Results -
May 29, 2023 Audited Results -
Feb 14, 2023 Quarterly Results -
Nov 11, 2022 Quarterly Results & Interim Dividend -
Aug 10, 2022 Quarterly Results -
May 24, 2022 Audited Results & Amalgamation -
Feb 14, 2022 Quarterly Results -
Nov 13, 2021 Qtr Results, Int. Dividend & Stock Split -
Aug 05, 2021 Quarterly Results -
May 28, 2021 Audited Results -
Feb 04, 2021 Quarterly Results -
Nov 07, 2020 Quarterly Results & Interim Dividend -
Sep 02, 2020 Preferential Issue of shares -
Aug 10, 2020 Quarterly Results -
Jun 16, 2020 Audited Results -
Feb 12, 2020 Quarterly Results -
Nov 07, 2019 Quarterly Results -
Sep 26, 2019 Issue Of Warrants -
Aug 13, 2019 Quarterly Results -
May 29, 2019 Audited Results & Final Dividend -
Feb 12, 2019 Quarterly Results -
Nov 14, 2018 Quarterly Results -
Aug 09, 2018 Quarterly Results -
May 29, 2018 Audited Results & Dividend -
Feb 07, 2018 Quarterly Results -
Nov 14, 2017 Quarterly Results -
Aug 11, 2017 Quarterly Results -
May 28, 2017 Audited Results & Dividend -
Apr 25, 2017 Others To consider grant of options under Ipca Laboratories Ltd. - Employees Stock Option Scheme - 2014 (ESOS) as sanctioned by the shareholders at the 64th A.G.M of the Com.
Feb 10, 2017 Quarterly Results -
Nov 11, 2016 Quarterly Results -
Aug 11, 2016 Quarterly Results -
May 30, 2016 Audited Results -
Feb 08, 2016 Quarterly Results -
Oct 30, 2015 Quarterly Results -
Jul 30, 2015 Quarterly Results -
May 30, 2015 Audited Results & Dividend -
Feb 07, 2015 Quarterly Results -
Nov 10, 2014 Quarterly Results -
Jul 31, 2014 Quarterly Results -
May 29, 2014 Audited Results & Final Dividend -
Jan 28, 2014 Quarterly Results -
Oct 24, 2013 Quarterly Results & Interim Dividend -
Jul 30, 2013 Quarterly Results -
May 30, 2013 Audited Results & Final Dividend -
Jan 30, 2013 Quarterly Results & ESOP To consider : Allotment of 48,750 equity shares of Rs. 2/- each on exercise of options under Ipca Laboratories Ltd - Employees Stock Option Scheme - 2006 (ESOS).
Oct 25, 2012 Quarterly Results & Interim Dividend -
Jul 31, 2012 Quarterly Results -
May 29, 2012 Audited Results & Final Dividend -
May 16, 2012 Others 1. The order passed by the Hon'ble High Court of Judicature at Bombay and Hon'ble High Court of Gujarat approving the Scheme of Amalgamation of M/s. Tonira Pharma Ltd. with the Company.
Apr 13, 2012 Appointment of Additional Director The Board has appointed Mr. Dev Parkash Yadava as an Additional Director of the Company with immediate effect.
Jan 31, 2012 Quarterly Results & 2nd Interim Dividend -
Jan 20, 2012 Employees Stock Option Plan The Board has alloted of 1,21,250 fully paid-up Equity Shares of Rs. 2/- each of the Company @ Rs. 63/- per Equity Share to whom options were granted on October 29, 2007 & November 11, 2008.
Oct 31, 2011 Quarterly Results & Interim Dividend -
Sep 17, 2011 To consider the Amalgamation Inter-alia, to consider the Amalgamation / Merger of Tonira Pharma Limited with the Company.
Jul 28, 2011 Quarterly Results -
May 24, 2011 Audited Results & Final Dividend -
Jan 25, 2011 Qtrly Results, 3rd Intrm Dividend & ESOP For allotment of Equity Shares on exercise of options under Ipca Laboratories Ltd - Employees Stock Option Scheme - 2006 (ESOS).
Oct 22, 2010 Quarterly Results & Interim Dividend -
Jul 29, 2010 Quarterly Results -
May 28, 2010 Audited Results & Final Dividend -
Feb 25, 2010 To fix record date for Stock split inter alia, to fix the 'Record Date' for deciding the Members entitlement of sub-divided Shares.
Jan 21, 2010 Qtr Results, Int.Dividend & Stock Split To consider the stock split of 5 Equity Shares of Rs. 2/- each for every 1 Equity Share of Rs. 10/- each & to allot of 14,250 fully paid-up Equity Shares of Rs 10/- each @ Rs. 315/- per Equity Share.
Dec 10, 2009 Employees Stock Option Plan & Others The Board has allotted 95,500 Equity Shares of Rs. 10/- each under the followings: 1. 77,250 fully paid-up Equity Shares of Rs. 10/- each. 2. 18,250 fully paid-up Equity Shares of Rs. 10/- each.
Nov 03, 2009 Others inter-alia, to consider closure of the on going Buy-back of own fully paid Equity Shares of the Company from open market purchase through Stock Exchanges.
Oct 27, 2009 Quarterly Results & Interim Dividend -
Jul 30, 2009 Quarterly Results -
May 28, 2009 Audited Results & Final Dividend -
Jan 22, 2009 Quarterly Results & Interim Dividend -
Nov 11, 2008 Buy Back of Shares & ESOP To allot 57,000 options to selected permanent employees of the Co. under Ipca Laboratories Ltd ESOS & to buy back of Company's own fully paid-up equity shares of Rs 10/- each from open market.
Oct 31, 2008 Qtr. Results, Intrm. Dividend & ESOP -
Oct 30, 2008 Others To accept the resignation by Shri. Gaurav Mathur from the directorship of the Company & to appoint Shri. Kumar Krishnan Iyer as an Additional Director of the Company.
Jul 25, 2008 Quarterly Results -
May 29, 2008 Audited Results & Dividend -
Jan 19, 2008 Quarterly Results -
Oct 29, 2007 Employees Stock Option Plan -
Jul 20, 2007 Quarterly Results -
May 25, 2007 Audited Results & Final Dividend -
Jan 23, 2007 Quarterly Results -
Oct 18, 2006 Qtr. Results, Dividend & Int. Dividend -
Sep 23, 2006 To consider grant of options To consider grant of options to selected permanent employees and Directors.
Jul 28, 2006 Quarterly Results -
May 30, 2006 Accounts, Final Dividend & ESOS -
Jan 19, 2006 Quarterly Results -
Oct 28, 2005 Quarterly Results & Interim Dividend -
Aug 12, 2005 Accounts/Amalgamation To consider and take on record Order of the Board for Industrial & Financial Reconstruction (BIFR) ordering the amalgamation with the Company of Innotech Pharma Ltd (wholly owned subsidiary).
Jul 29, 2005 Quarterly Results (Revised)
Jun 28, 2005 Final Dividend & Accounts -
Jan 29, 2005 Quarterly Results -
Dec 25, 2004 Others To fix the record date for members entitlement of Bonus shares.
Oct 27, 2004 Qtr Results, I. Dividend & Bonus issue -
Jul 27, 2004 Quarterly Results -
Jun 29, 2004 Accounts & Second Interim Dividend -
Feb 27, 2004 Others E.G.M. To consider merger of Infotech Pharma Ltd. with the company.
Jan 30, 2004 Quarterly Results -
Oct 18, 2003 Quarterly Results -
Jul 24, 2003 Quarterly Results -
Jun 12, 2003 Dividend & Accounts -
Jan 25, 2003 Quarterly Results -
Oct 24, 2002 Quarterly Results -
Jul 19, 2002 Quarterly Results -
Jun 11, 2002 Accounts & Dividend -
Mar 04, 2002 Interim Dividend (Revised)
Jan 30, 2002 Quarterly Results and nine months -
Nov 03, 2001 Quarterly Results & Half Yearly Results (Revised)
Jul 26, 2001 Quarterly Results -
May 10, 2001 Dividend & Accounts -
Jan 25, 2001 Quarterly Results -
Oct 19, 2000 Quarterly Results -
Jun 22, 2000 Accounts -
Mar 23, 2000 Interim Dividend -
Jan 31, 2000 Quarterly Results -
Oct 28, 1999 Quarterly Results & Interim Dividend -
Jul 28, 1999 Quarterly Results -
Jan 25, 1999 Quarterly Results -
Oct 28, 1998 Half Yearly Results & Interim Dividend -
Jun 25, 1998 Accounts & Final Dividend -
Oct 21, 1997 Half Yearly Results & Interim Dividend -
Ex-Date Bonus Ratio Record Date
Jan 28, 2005 1:1 2005-01-31
Bigul
28 Jun 2024

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of Duplicate Share Certificate
Bigul
27 Jun 2024

IPCA LABORATORIES LTD. - 524494 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Judgement of Court of Justice of the EU
Bigul
21 Jun 2024

IPCA LABORATORIES LTD. - 524494 - Closure of Trading Window

 Closure of Trading Window
Bigul
14 Jun 2024

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of Duplicate Share Certificate
Bigul
03 Jun 2024

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Transcript of the Earnings Call
Bigul
31 May 2024

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of Duplicate Share Certificate
Bigul
31 May 2024

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Audio Link of the Conference Call held on 30.05.2024
31 May 2024

Ipca Laboratories Results Earnings Call for Q4FY24

 Conference Call with Ipca Laboratories Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Bigul
30 May 2024

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copy of Newspaper Publication
Bigul
29 May 2024

IPCA LABORATORIES LTD. - 524494 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report for the year ended March 31, 2024
See all News

FAQs

The latest market price of Ipca Laboratories Ltd. on NSE was Rs. 1175.75 as of today.

The opening share price of Ipca Laboratories Ltd. was Rs. 1162.00 as of today.

The 52-week high share price of Ipca Laboratories Ltd. was Rs. 1374.60.

The 52 week low share price of Ipca Laboratories Ltd. was Rs. 743.00.

Ipca Laboratories Ltd. has a market cap of Rs. 29829.30 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Ipca Laboratories Ltd. is 3.40. Please refer to the Fundamentals section for further details.

The operating revenue for Ipca Laboratories Ltd. in the last FY was Rs.  7707.41 crore. Please refer to the Financials section for further details.

The Net Profit for Ipca Laboratories Ltd. in the last FY was Rs. 547.35 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Ipca Laboratories Ltd. was on 2023-11-22 for Rs. 2 per share. According to today’s share price, the dividend yield of Ipca Laboratories Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Ipca Laboratories Ltd. was as of 2005-01-28. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Ipca Laboratories Ltd. was as of 2010-03-22. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Ipca Laboratories Ltd..

Close

Let's Open Free Demat Account